跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,619 条关于
“Trypsin-Activated Abuse Protection”
全部
9,619
临床试验
5,230
药物
661
机构
56
资讯
3,672
去年
Ensysce Biosciences Secures Patent for Novel Methadone-Based Opioid Use Disorder Treatment
9个月前
Ensysce Biosciences Enrolls First Patient in Pivotal Phase 3 Trial for Abuse-Resistant Opioid PF614
3年前
Ensysce Biosciences Advances Abuse-Deterrent and Overdose-Protection Opioid Programs
去年
Ensysce Biosciences Secures Supply and Partnership to Advance Abuse-Resistant Pain Relief
去年
Ensysce Biosciences Advances Abuse-Resistant Opioids PF614 and PF614-MPAR Towards Market
9个月前
Ensysce Biosciences Secures Extended Patent Protection for MPAR Overdose Prevention Technology Through 2042
10个月前
Ensysce Biosciences Advances PF614 Phase 3 Trial with FDA Manufacturing Approval and Extended Patent Protection
去年
Ensysce Biosciences Strengthens Regulatory Team Ahead of Critical Phase 3 Trials and NDA Submission
去年
Ensysce Biosciences Secures Patent for Novel Opioid Use Disorder Treatment PF9001
11个月前
Nutriband Files Patent Application to Strengthen Abuse-Deterrent Technology for Opioid Patches
第 1 页，共 368 页
上一页
下一页
